<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00738192</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-FY2008-311</org_study_id>
    <secondary_id>NJFY0807311M</secondary_id>
    <nct_id>NCT00738192</nct_id>
  </id_info>
  <brief_title>Comparison of Analgesic Efficacy of Fentanyl, Sufentanil and Butorphanol After Remifentanil Anesthesia</brief_title>
  <acronym>CARAN</acronym>
  <official_title>Comparison of Analgesic Efficacy of Fentanyl, Sufentanil and Butorphanol After Remifentanil Anesthesia in Gynecological Laparoscopic Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fast awakening from anesthesia is one of the major characteristics of remifentanil-associated
      anesthetic induction and maintenance, whereas corresponding pain during awakening influences
      patient's rehabilitation strongly. In addition, such early postoperative pain results in
      significant stress responses, which displays as further release of stress hormones such as
      cortisol and β-endorphin as well. How to prevent such acute pain resulting from
      remifentanil's fast metabolism endows clinical significance. This study is designed to
      compare the analgesic efficacy of fentanyl, sufentanil and butorphanol delivered after
      gynecological laparoscopic surgeries that underwent remifentanil induction and maintenance,
      and investigate corresponding influence on the levels of blood cortisol and β-endorphin.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VAS ratings of pain</measure>
    <time_frame>0 min after awake from anesthesia; 5,10,15,20 and 30min after awake from anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hemodynamics of patients</measure>
    <time_frame>30min before operation; every 10min during operation; 5,10,15,20,30 and 60min after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedative ratings with VAS system</measure>
    <time_frame>0,5,10,15,25,45 and 60min after awake from anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall VAS satisfaction ratings</measure>
    <time_frame>1 h after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood cortisol and β-endorphin levels</measure>
    <time_frame>0, 10min before the end of surgeries, 10min, 1h and 6h after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>1 h after operation</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl delivered for controlling awaking pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Sufentanil delivered for controlling awaking pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Butorphanol delivered for controlling awaking pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl citrate</intervention_name>
    <description>Fentanyl 0.5 μg/kg delivered intravenously immediate at the end of remifentanil pump finished</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Fentanil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sufentanil citrate</intervention_name>
    <description>Sufentanil 0.05 μg/kg delivered intravenously immediate at the end of remifentanil pump finished</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Sufenil</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Butorphanol tartrate</intervention_name>
    <description>Butorphanol 0.01 mg/kg delivered intravenously immediate at the end of remifentanil pump finished</description>
    <arm_group_label>3</arm_group_label>
    <other_name>Nuoyung</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ASA physical status I-II

          2. Chinese

          3. 19-45yr

          4. Selective laparoscopic surgeries

        Exclusion Criteria:

          1. Allergy to opioids, a history of the use of centrally-acting drugs of any sort,
             chronic pain and psychiatric diseases records

          2. Participants younger than 18 years, older than 45 years or pregnancy was eliminated

          3. Due to the significant changes in vital signs might affect cognition of pain and that
             of sensation, over 20% variation of these records from the baselines or below 92% of
             SpO2 under 20-40% nasal tube oxygen at any time should be excluded from the study

          4. Those who were not willing to or could not finish the whole study at any time
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Maternal and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2008</study_first_submitted>
  <study_first_submitted_qc>August 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 20, 2008</study_first_posted>
  <last_update_submitted>March 10, 2009</last_update_submitted>
  <last_update_submitted_qc>March 10, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2009</last_update_posted>
  <responsible_party>
    <name_title>XiaoFeng Shen</name_title>
    <organization>Nanjing Medical University</organization>
  </responsible_party>
  <keyword>Postoperative analgesia</keyword>
  <keyword>Opioids</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Butorphanol</mesh_term>
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Citric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

